secwatch.observer — SEC 8-K summary
======================================

Issuer:     NU SKIN ENTERPRISES, INC. (NUS)
CIK:        0001021561
Form:       8-K
Filed at:   2026-08-21T20:06:02+00:00
Accession:  0001140361-26-034016
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Nu Skin EVP & President of Global Sales Justin Keisel begins medical leave
--------------------------------------------------------------------------

- Justin Keisel, EVP and President of Global Sales, began medical leave effective Aug 17, 2026.
- Chayce Clark, EVP/COO/Chief Legal Officer, will lead Keisel's organization during his absence.
- Company says it wishes Keisel and family best as he focuses on health; no return date given.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1021561/000114036126034016/0001140361-26-034016-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1021561/000114036126034016/ef20080794_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-034016

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer